Position in EXEL
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$316,557
+$57,459 QoQ
Shares Held
5,818
-3.7% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#506
of 751 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Meiji Yasuda Asset Management Co Ltd. holds $10,170,872 across 12 Biotechnology names. EXEL ranks #8 (3.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
12,740 | $6,328,340 | |
| 2 | INCY |
Incyte Corp
|
5,097 | $577,795 | |
| 3 | RPRX |
Royalty Pharma plc
|
8,098 | $454,054 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
7,780 | $445,171 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
10,402 | $368,126 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,452 | $349,888 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,085 | $326,617 | |
| 8 | EXEL |
Exelixis, Inc.
This page
|
5,818 | $316,557 |
All Filings in EXEL
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $316,557 | 5,818 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $259,098 | 6,041 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $269,642 | 6,152 | Shares | Defined | 2026-02-06 | |
| 2025-09-30 | $258,331 | 6,255 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $288,283 | 6,540 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $246,256 | 6,670 | Shares | Defined | 2025-05-16 | |
| 2024-12-31 | $233,732 | 7,019 | Shares | Defined | 2025-02-12 | |
| No filing history on record for this holder in this stock. | ||||||